Vorasidenib Alternatives Compared
| Vorasidenib | Voranigo (vorasidenib) | Bevacizumab |
|
|---|
| Vorasidenib | Voranigo (vorasidenib) | Bevacizumab |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Malignant Glioma. Vorasidenib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Malignant Glioma. Voranigo may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Glioblastoma Multiforme, Colorectal Cancer, Fallopian Tube Cancer, Breast Cancer, Cervical Cancer, Breast Cancer - Metastatic, Hepatocellular Carcinoma, Macular Degeneration, Malignant... View more |
Related suggestions Malignant Glioma
|
|||||||
| More about Vorasidenib | More about Voranigo (vorasidenib) | More about Bevacizumab | ||||||||
| Ratings & Reviews | ||||||||||
|
Vorasidenib has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Voranigo has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Bevacizumab has an average rating of 7.6 out of 10 from a total of 37 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
|
View all Vorasidenib side effects |
View all Voranigo side effects |
View all Bevacizumab side effects |
||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Voranigo prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
|
N/A |
||||||||
| Brand Names | ||||||||||
| Voranigo |
N/A |
Alymsys, Avastin, Avzivi, Jobevne, Mvasi, Vegzelma, Zirabev | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
240 hours |
240 hours |
480 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 440 drugs are known to interact with Vorasidenib:
|
A total of 440 drugs are known to interact with Voranigo:
|
A total of 54 drugs are known to interact with Bevacizumab:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
August 06, 2024 |
August 06, 2024 |
N/A |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
|
||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.